From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study-Reference-Cited by-同舟云学术

From risk factor assessment to cardiovascular disease risk and mortality modification: the first 40 years of the Brisighella Heart Study

Published:2011-06-01 Issue:3 Volume:6 Page:269-276
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Cicero Arrigo¹,Dormi Ada¹,D’Addato Sergio¹,Borghi Claudio¹,Study Staff Brisighella Heart¹

Affiliation:

1. Internal Medicine, Aging and Kidney diseases Department, Sant’Orsola-Malpighi University Hospital, Poliambulatorio Pad., 2 – Via Albertoni, 15, E1 2AT, 40138, Bologna, Italy

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.11.23

Reference42 articles.

1. Muchiteni T, Borden WB: Improvingrisk factor modification: a global approach. Curr. Cardiol. Rep. 11(6), 476–483(2011).

2. Vanuzzo D, Pilotto L, Uguccioni M et al.: Cardiovascular epidemiology: trends of risk factors in Italy. Ital. Heart J. 5(Suppl. 8), S19–S27 (2004).

3. Volpato S, Vigna GB, McDermott MM et al.: Lipoprotein(a), inflammation,and peripheral arterial disease in a community based sample of older menand women (the InCHIANTI study). Am. J. Cardiol. 105(12), 1825–1830 (2010).

4. Noto D, Barbagallo CM, Cefalö ABet al.: The metabolic syndrome predicts cardiovascular events in subjects withnormal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis 197(1), 147–153 (2008).

5. Tsimikas S, Willeit J, Knoflach M et al.: Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10 year cardiovascular and non-cardiovascular mortality: results from the Bruneck study. Eur. Heart J. 30(1), 107–115 (2011).

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From classical to innovative clinical epidemiology: the 50 years' experience of the Brisighella Heart Study;Panminerva Medica;2021-12

2. Synergistic actions between angiotensin-converting enzyme inhibitors and statins in atherosclerosis;Nutrition, Metabolism and Cardiovascular Diseases;2021-11

3. Serum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart Study;Scientific Reports;2018-08-01

4. Renin–angiotensin system at the crossroad of hypertension and hypercholesterolemia;Nutrition, Metabolism and Cardiovascular Diseases;2017-02

5. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects;European Journal of Internal Medicine;2017-01